BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35276341)

  • 1. Vaginal microbiome and cervical cancer.
    Kyrgiou M; Moscicki AB
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):189-198. PubMed ID: 35276341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression.
    Liu H; Liang H; Li D; Wang M; Li Y
    Microbiol Spectr; 2022 Oct; 10(5):e0015122. PubMed ID: 36036584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity.
    Mitra A; MacIntyre DA; Lee YS; Smith A; Marchesi JR; Lehne B; Bhatia R; Lyons D; Paraskevaidis E; Li JV; Holmes E; Nicholson JK; Bennett PR; Kyrgiou M
    Sci Rep; 2015 Nov; 5():16865. PubMed ID: 26574055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
    Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
    BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
    Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
    Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Complex Interplay between Vaginal Microbiota, HPV Infection, and Immunological Microenvironment in Cervical Intraepithelial Neoplasia: A Literature Review.
    Gardella B; Pasquali MF; La Verde M; Cianci S; Torella M; Dominoni M
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
    Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
    Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection.
    Huang J; Yin C; Wang J
    J Obstet Gynaecol; 2023 Dec; 43(1):2161349. PubMed ID: 36645341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status.
    Ma Y; Li Y; Liu Y; Cao L; Han X; Gao S; Zhang C
    J Microbiol; 2023 Apr; 61(4):423-432. PubMed ID: 37010797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study.
    Caselli E; D'Accolti M; Santi E; Soffritti I; Conzadori S; Mazzacane S; Greco P; Contini C; Bonaccorsi G
    Front Cell Infect Microbiol; 2020; 10():540900. PubMed ID: 33251154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN).
    Mathur SP; Mathur RS; Rust PF; Young RC
    Am J Reprod Immunol; 2001 Oct; 46(4):280-7. PubMed ID: 11642677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
    Gonçalves-Nobre JG; Matos A; Carreira M; Santos AC; Veiga LC; Ginete C; Brito M; Pires M; Pereira H; Cardoso C; Bicho M; Bicho MC
    Front Cell Infect Microbiol; 2023; 13():1251913. PubMed ID: 38532749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study.
    Wiik J; Sengpiel V; Kyrgiou M; Nilsson S; Mitra A; Tanbo T; Monceyron Jonassen C; Møller Tannæs T; Sjøborg K
    BMC Womens Health; 2019 Feb; 19(1):30. PubMed ID: 30728029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia.
    Kumari S; Bhor VM
    Microb Pathog; 2021 Mar; 152():104780. PubMed ID: 33545325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
    Ilhan ZE; Łaniewski P; Thomas N; Roe DJ; Chase DM; Herbst-Kralovetz MM
    EBioMedicine; 2019 Jun; 44():675-690. PubMed ID: 31027917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome and Cervical Cancer.
    Castanheira CP; Sallas ML; Nunes RAL; Lorenzi NPC; Termini L
    Pathobiology; 2021; 88(2):187-197. PubMed ID: 33227782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer.
    Alimena S; Davis J; Fichorova RN; Feldman S
    Curr Probl Cancer; 2022 Aug; 46(4):100877. PubMed ID: 35709613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between human papillomavirus and vaginal microbiota in cervical cancer development.
    Sharifian K; Shoja Z; Jalilvand S
    Virol J; 2023 Apr; 20(1):73. PubMed ID: 37076931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
    Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
    Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.